Can a low-cost OCT device aid research and improve disease diagnosis in low-income settings?
When you crunch the numbers on drug development, are the costs of cancer drugs justified?
Research shows that art training can improve ophthalmologists’ observational skills.
We need to explain the context when using “grab bag” phrases in science and medicine
Are mouse models the best option we have?
Patient-centric healthcare can only be fully achieved if we change the current organizational methods
Jayasree K. Iyer
Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands
Karen Nichols and Jacques Galipeau
We want faster translation of cell therapies, but is it worth sacrificing public trust?
Boston leads the drug discovery field, and the UK could soon follow suit
Jef Boeke, Professor, Department of Biochemistry and Molecular Pharmacology at NYU
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.